Creatine Monohydrate
Dietary SupplementCreatine monohydrate (5.0 g creatine monohydrate, 1.5 g dextrose)
NCT Number: NCT03000582
The purpose of this study is to examine the pharmacokinetics of creatine nitrate supplementation.
Looking for future studies?
Notify MeCreatine nitrate contains several nutrients that may increase anaerobic exercise performance. Theoretically, dietary supplementation of creatine nitrate during resistance training can improve the quality of training leading to greater changes in strength, power and fat free mass. Endothelial function measured by flow-mediated dilation (FMD), a non-invasive vascular health parameter that can be measured via ultrasonography, is a predictor of cardiovascular disease risk which precedes traditional risk markers. Diet, physical activity and pharmaceutical interventions can all impact vascular function and health. The purpose of this study is to determine the acute vascular response of creatine nitrate supplementation on FMD by analyzing the pharmacokinetics of creatine nitrate supplementation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Creatine monohydrate (5.0 g creatine monohydrate, 1.5 g dextrose)
Creatine nitrate-1 (1.0 g creatine monohydrate, 0.5 g nitrate, 5.0 g dextrose)
Creatine nitrate-2 (2.0 g creatine monohydrate, 1.0 g nitrate, 3.5 g dextrose)
Placebo (6.5 g dextrose)
Time frame: One day
Time frame: One day
Time frame: One day
Time frame: One day
Time frame: One day
Time frame: One day
Time frame: One day
Time frame: One day
Time frame: One day
Time frame: One day
Texas A&M University
Other
Pharmacokinetic Assessment of Acute Ingestion of Different Forms of Creatine
Acronym: NB3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03495986
Behavior, Central Nervous System Diseases
Miami, Florida, United States
View Trial DetailsNCT03796897
Behavior, Behavior, Animal
Hamilton, Ontario, Canada
View Trial DetailsNCT02772952
Behavior, Dietary Modification
Málaga, Spain
View Trial DetailsNCT03781011
Cardiovascular Diseases, Dietary Modification
Taipei, Taiwan
View Trial Details